AR026605A1 - Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacos - Google Patents

Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacos

Info

Publication number
AR026605A1
AR026605A1 ARP000106216A ARP000106216A AR026605A1 AR 026605 A1 AR026605 A1 AR 026605A1 AR P000106216 A ARP000106216 A AR P000106216A AR P000106216 A ARP000106216 A AR P000106216A AR 026605 A1 AR026605 A1 AR 026605A1
Authority
AR
Argentina
Prior art keywords
neuromuscular
mercapto
derivative
sureversion
pharmacos
Prior art date
Application number
ARP000106216A
Other languages
English (en)
Spanish (es)
Original Assignee
Adam Worrall Julia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8241767&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR026605(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Adam Worrall Julia filed Critical Adam Worrall Julia
Publication of AR026605A1 publication Critical patent/AR026605A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ARP000106216A 1999-11-29 2000-11-27 Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacos AR026605A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99309558 1999-11-29

Publications (1)

Publication Number Publication Date
AR026605A1 true AR026605A1 (es) 2003-02-19

Family

ID=8241767

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106216A AR026605A1 (es) 1999-11-29 2000-11-27 Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacos

Country Status (33)

Country Link
US (3) US6670340B1 (enEXAMPLES)
EP (1) EP1259550B1 (enEXAMPLES)
JP (2) JP3880041B2 (enEXAMPLES)
KR (1) KR100716524B1 (enEXAMPLES)
CN (1) CN1188428C (enEXAMPLES)
AR (1) AR026605A1 (enEXAMPLES)
AT (1) ATE288450T1 (enEXAMPLES)
AU (1) AU776536B2 (enEXAMPLES)
BE (1) BE2008C047I2 (enEXAMPLES)
BR (1) BRPI0015947B8 (enEXAMPLES)
CA (1) CA2390463C (enEXAMPLES)
CO (1) CO5251450A1 (enEXAMPLES)
CY (1) CY2008018I2 (enEXAMPLES)
CZ (1) CZ298206B6 (enEXAMPLES)
DE (2) DE122008000068I2 (enEXAMPLES)
DK (1) DK1259550T3 (enEXAMPLES)
ES (1) ES2237496T3 (enEXAMPLES)
FR (1) FR08C0052I2 (enEXAMPLES)
HU (1) HU227451B1 (enEXAMPLES)
IL (1) IL149423A0 (enEXAMPLES)
LU (1) LU91501I2 (enEXAMPLES)
MX (1) MXPA02004940A (enEXAMPLES)
NL (1) NL300356I2 (enEXAMPLES)
NO (2) NO328790B1 (enEXAMPLES)
NZ (1) NZ518752A (enEXAMPLES)
PE (1) PE20010902A1 (enEXAMPLES)
PL (1) PL203012B1 (enEXAMPLES)
PT (1) PT1259550E (enEXAMPLES)
RU (1) RU2260013C2 (enEXAMPLES)
SK (1) SK286282B6 (enEXAMPLES)
TW (1) TWI242015B (enEXAMPLES)
WO (1) WO2001040316A1 (enEXAMPLES)
ZA (1) ZA200203538B (enEXAMPLES)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6744471B1 (en) * 1997-12-05 2004-06-01 Olympus Optical Co., Ltd Electronic camera that synthesizes two images taken under different exposures
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
US20040048830A1 (en) * 2000-11-02 2004-03-11 Mingqiang Zhang Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
BRPI0415637A (pt) 2003-10-31 2006-12-12 Univ Kansas derivados de sulfoalquil éter-alquil éter ciclodextrina
JP2007538112A (ja) 2004-01-29 2007-12-27 ピナクル ファーマシューティカルズ β−シクロデキストリン誘導体およびそれらの炭疽致死毒に対する使用
DK3520779T3 (da) 2004-04-23 2022-03-21 Cydex Pharmaceuticals Inc DPI formulering indeholdende sulfoalkylethercyclodextrin
MX2007010129A (es) 2005-01-28 2007-11-16 Pinnacle Pharmaceuticals Inc Derivados de beta-ciclodextrina como agentes antibacteriales.
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
MX348982B (es) 2005-10-26 2017-07-06 Cydex Pharmaceuticals Inc Composiciones de eter sulfoalquilico-ciclodextrina y metodos de preparacion de las mismas.
US20090069412A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched sugammadex
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
US7938283B2 (en) * 2008-06-20 2011-05-10 Grainpro, Inc. System and method for hermetic storage of agricultural commodities during shipping
WO2010053487A1 (en) 2008-11-07 2010-05-14 Cydex Pharmaceuticals, Inc. Composition containing sulfoalkyl ether cyclodextrin and latanoprost
CN101591402B (zh) * 2009-05-05 2011-11-30 杭州奥默医药技术有限公司 6-脱氧砜类环糊精衍生物及其制备方法
US8492538B1 (en) 2009-06-04 2013-07-23 Jose R. Matos Cyclodextrin derivative salts
DE102010012281A1 (de) * 2010-03-22 2011-09-22 Fresenius Medical Care Deutschland Gmbh Pharmazeutische Zusammensetzungen enthaltend substituiertes 6-Deoxy-6-sulfanylcyclodextrin
CN101864003B (zh) * 2010-06-11 2012-05-02 漆又毛 一种6-脱氧硫醚氨基酸环糊精衍生物的合成方法
ES2551585T3 (es) * 2010-08-25 2015-11-20 Davuluri, Ramamohan Rao Procedimiento mejorado para la preparación de Sugammadex
CN102060941B (zh) * 2010-11-26 2012-12-26 漆又毛 6-脱氧α-氨基酸衍生物环糊精及制备和应用
EP2814849B8 (en) 2012-02-15 2020-03-04 CyDex Pharmaceuticals, Inc. Manufacturing process for cyclodextrin derivatives
EP2748205A4 (en) 2012-02-28 2014-07-30 Cydex Pharmaceuticals Inc ALKYLATED COMPOSITIONS BASED ON CYCLODEXTRIN AND METHOD FOR THE PREPARATION AND USE THEREOF
JP5892847B2 (ja) * 2012-04-27 2016-03-23 Ｄｏｗａホールディングス株式会社 シクロデキストリンとシリカ含有物質との複合材料、及びその製造方法、並びにガス吸着剤
GB201211153D0 (en) * 2012-06-22 2012-08-08 Farmhispania Pharmaceutical compositions
UA121095C2 (uk) 2012-10-22 2020-04-10 Сідекс Фармасьютікалс, Інк. Композиції алкілованого циклодекстрину і способи їх одержання і застосування
WO2014125501A1 (en) 2013-02-14 2014-08-21 Neuland Laboratories Limited An improved process for preparation of sugammadex sodium
US10662260B2 (en) 2014-05-29 2020-05-26 Uti Limited Partnership Cyclodextrin-based polyanionic and non-ionic dendrimers
AU2014398349B2 (en) 2014-06-26 2020-08-06 Maruishi Pharmaceutical Co., Ltd. Rocuronium preparation with improved stability
US10851184B2 (en) 2014-08-22 2020-12-01 Cydex Pharmaceuticals, Inc. Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same
CN105348412B (zh) * 2014-08-22 2018-06-05 江苏恩华药业股份有限公司 一种舒更葡糖钠的纯化方法
EP4620534A2 (en) 2015-03-19 2025-09-24 CyDex Pharmaceuticals, Inc. Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
CN104844732B (zh) * 2015-03-27 2017-05-03 山东滨州智源生物科技有限公司 一种舒更葡糖钠的制备方法
EP3280740A4 (en) * 2015-04-08 2019-03-27 Ling, Chang-Chun PHARMACEUTICAL COMPOSITIONS OF POLYANIONIC AND NONIONIC CYCLODEXTRIN BASED DENDRIMERS AND USES THEREOF
EP3303413A4 (en) * 2015-05-29 2019-02-06 Alaparthi, Lakshmi Prasad PROCESS FOR THE PREPARATION OF SUGAMMADEX AND INTERMEDIATE PRODUCTS THEREOF
CN104922693A (zh) * 2015-06-19 2015-09-23 南开大学 一种阴离子型环糊精与抗癌药物包合物及制备方法
US20180280537A1 (en) * 2015-10-07 2018-10-04 Uti Limited Partnership Multifunctional polyanionic cyclodextrin dendrimers
EP3741801A1 (en) 2015-11-25 2020-11-25 Fresenius Kabi iPSUM S.r.l. Crystalline forms of per-chloro-gamma-cyclodextrines
ES2829236T3 (es) * 2015-11-25 2021-05-31 Fresenius Kabi Ipsum S R L Procedimiento mejorado para la preparación de sugammadex y sus productos intermedios
WO2017163165A1 (en) 2016-03-22 2017-09-28 Fresenius Kabi Anti-Infectives S.r.l. An improved process for the preparation of sugammadex
HUE050532T2 (hu) * 2016-04-29 2020-12-28 Alveron Pharma B V Ciklodextrinek prokoagulánsként
ES2915423T3 (es) 2016-06-23 2022-06-22 Synthon Bv Proceso de preparación de sugammadex
US10526422B2 (en) 2016-06-29 2020-01-07 Beijing Creatron Institute Of Pharmaceutical Research Co., Ltd. Process for preparation and purification of Sugammades sodium
WO2017084401A1 (zh) 2016-06-29 2017-05-26 北京睿创康泰医药研究院有限公司 舒更葡糖钠的制备及纯化方法
CN107778383B (zh) * 2016-08-24 2020-03-10 王炳永 一种舒更葡糖钠的精制方法
US10385142B2 (en) 2017-01-23 2019-08-20 Scinopharm Taiwan, Ltd. Method for preparing sugammadex sodium
AU2018263924B2 (en) 2017-05-03 2024-07-04 Cydex Pharmaceuticals, Inc. Composition containing cyclodextrin and busulfan
CN109021148B (zh) * 2017-06-08 2020-11-10 天津科伦药物研究有限公司 一种制备舒更葡糖钠的方法
US10442871B2 (en) * 2017-06-22 2019-10-15 Lawrence Livermore National Security, Llc Modified cyclodextrins for the selective sequestration of fentanyl related compounds and uses thereof
EP3421504B1 (en) 2017-06-30 2019-09-18 Synthon B.V. Process for making sugammadex
US10233263B1 (en) * 2017-08-23 2019-03-19 Formosa Laboratories, Inc. Method for preparation of sugammadex sodium
TWI703163B (zh) * 2017-08-23 2020-09-01 台耀化學股份有限公司 舒更葡糖鈉之製備方法及其晶型
CN107892727B (zh) * 2017-11-27 2019-12-24 合肥博思科创医药科技有限公司 一种舒更葡糖钠的纯化方法
ES2948930T3 (es) 2017-11-27 2023-09-21 Medichem Sa Proceso para la síntesis de un derivado de ciclodextrina
EP4047047A1 (en) 2018-04-06 2022-08-24 Synthon B.V. Purification of sugammadex
KR102054228B1 (ko) 2018-05-28 2019-12-10 연성정밀화학(주) 슈가마덱스 나트륨염의 제조방법
WO2019236436A1 (en) 2018-06-07 2019-12-12 Merck Sharp & Dohme Corp. Processes for the preparation of sugammadex
CN110615860A (zh) * 2018-06-20 2019-12-27 江苏恒瑞医药股份有限公司 一种舒更葡糖钠的纯化方法
EP3830184B1 (en) * 2018-08-02 2025-04-30 TAPI Croatia Industries Ltd Solid state forms of sugammadex sodium
US11845811B2 (en) 2018-09-20 2023-12-19 Natco Pharma Limited Process for the preparation of Sugammadex sodium and its novel polymorphic form
US20220049023A1 (en) 2018-09-27 2022-02-17 Werthenstein Biopharma Gmbh Novel crystalline forms of sugammadex
JP6950966B2 (ja) * 2018-11-01 2021-10-13 丸石製薬株式会社 スガマデクス又はその薬理学的に許容される塩含有液剤及びその製造方法
CN109824800A (zh) * 2018-12-29 2019-05-31 鼎元(天津)生物医药科技有限公司 一种选择性肌松拮抗药舒更葡萄糖钠的制备方法
CN109438591B (zh) * 2018-12-29 2021-02-09 博瑞生物医药（苏州）股份有限公司 舒更葡糖钠的制备工艺
WO2020201930A1 (en) 2019-03-29 2020-10-08 Hospira, Inc. An improved process for preparation of sugammadex acid and sugammadex sodium
CN111978435B (zh) 2019-05-22 2021-05-25 合肥博思科创医药科技有限公司 一种高纯度舒更葡糖钠的制备方法
US11324692B2 (en) 2019-07-03 2022-05-10 Galenicum Health S.L.U. Method to prepare pharmaceutical compositions of suggamadex
EP4023292A4 (en) 2019-08-30 2023-09-06 TERUMO Kabushiki Kaisha INJECTION FORMULATION
RU2724900C1 (ru) * 2019-10-24 2020-06-26 Маруиси Фармасьютикал Ко., Лтд. Препарат рокурония с улучшенной стабильностью
CN111019016B (zh) * 2019-12-27 2022-02-18 武汉嘉诺康医药技术有限公司 一种舒更葡糖钠杂质的合成方法
JP2023515087A (ja) 2020-02-28 2023-04-12 メディチェム エセ．ア． スガマデクスを乾燥させるための方法
CN111714459B (zh) * 2020-06-18 2022-06-14 广州瑞尔医药科技有限公司 一种注射用舒更葡糖钠粉针剂及其制备方法
US11097023B1 (en) 2020-07-02 2021-08-24 Par Pharmaceutical, Inc. Pre-filled syringe containing sugammadex
EP3932391A1 (en) 2020-07-03 2022-01-05 Galenicum Health S.L.U. Method to prepare pharmaceutical compositions
US11446325B2 (en) * 2020-09-30 2022-09-20 Cyclolab Cyclodextrin Research And Development Laboratory Ltd. Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases
US11945788B2 (en) 2021-06-07 2024-04-02 Nuray Chemicals Private Limited Process for preparing pitolisant hydrochloride and solid-state forms thereof
CN113637097A (zh) * 2021-08-10 2021-11-12 北京恒创星远医药科技有限公司 6-全脱氧-6-全碘代-γ-环糊精晶体及其制备方法和应用
CN115708777A (zh) 2021-08-19 2023-02-24 北京费森尤斯卡比医药有限公司 包含巯基环糊精衍生物或其可药用盐的包装药品和保存方法
CN119679816A (zh) * 2023-09-15 2025-03-25 杭州奥默医药股份有限公司 一种用于逆转苄异喹啉类肌松药的肌松拮抗药物

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929813A (en) * 1973-12-26 1975-12-30 Interx Research Corp Novel pro-drug derivatives of pyridinium aldoxime type cholinesterase reactivators and process for preparing same
JPS52108027A (en) 1976-03-09 1977-09-10 Rikagaku Kenkyusho Anticarcinogen
US4816462A (en) 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
HU194858B (en) 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
IT1196033B (it) 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8506792D0 (en) 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
GB8613688D0 (en) 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (ja) 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
HU201783B (en) 1987-10-13 1990-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing partially methylized carboxy-acyl-beta-cyclodextrines and salts
US5017566A (en) 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
HUT58770A (en) 1989-04-03 1992-03-30 Janssen Pharmaceutica Nv Process for producing regioselective substituted cyclodextrines
US5173481A (en) 1989-04-03 1992-12-22 The United States Of America As Represented By The Department Of Health And Human Services Preparation of specifically substituted cyclodextrins
SU1703657A1 (ru) * 1990-01-23 1992-01-07 Пятигорский фармацевтический институт Соединение включени диэтиламида никотиновой кислоты и @ -циклодекстрина, про вл ющее пролонгированное аналептическое действие
EP0447171B1 (en) * 1990-03-15 1994-11-02 Tanabe Seiyaku Co., Ltd. Polysulfate of cyclodextrin derivative and process for preparing the same
US5180716A (en) 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
US5180176A (en) * 1991-08-08 1993-01-19 Far Great Plastics Industrial Co., Ltd. Elastic truck for roller skates
JP2556236B2 (ja) 1991-08-29 1996-11-20 田辺製薬株式会社 β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法
US5840881A (en) 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
US5767112A (en) 1994-10-21 1998-06-16 Poli Industria Chimica, S.P.A. Muscle relaxant pharmaceutical compositions
AU708107B2 (en) 1994-11-04 1999-07-29 Commonwealth Scientific And Industrial Research Organisation Method for treating animals
GB2307176A (en) * 1995-11-15 1997-05-21 Todd Selwyn Everest Anti-inflammatory clathrating agents for topical use
US5935941A (en) 1997-10-24 1999-08-10 Pitha; Josef Alkylations of cyclodextrins leading to derivatives which have a ridgidly extended cavity
US5834446A (en) * 1996-06-21 1998-11-10 Queen's University At Kingston Nerve process growth modulators
JP4249282B2 (ja) 1998-02-27 2009-04-02 日本食品化工株式会社 新規シクロデキストリン誘導体及びその製造方法
CA2330681C (en) 1998-05-29 2008-08-26 Andrea Giuffrida Control of pain with endogenous cannabinoids
US7265099B1 (en) * 1999-08-13 2007-09-04 Organon N.V. Use of chemical chelators as reversal agents for drug-induced neuromuscular block
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
US20020111377A1 (en) 2000-12-22 2002-08-15 Albany College Of Pharmacy Transdermal delivery of cannabinoids
US7026304B2 (en) 2001-02-14 2006-04-11 Akzo Nobel N.V. 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
TW200402417A (en) 2002-06-21 2004-02-16 Akzo Nobel Nv 1-[(Indol-3-yl)carbonyl]piperazine derivatives

Also Published As

Publication number Publication date
CZ20021814A3 (cs) 2002-08-14
PE20010902A1 (es) 2001-09-06
NL300356I1 (nl) 2008-10-01
LU91501I2 (fr) 2009-01-26
JP4563972B2 (ja) 2010-10-20
NO2010019I2 (no) 2012-08-27
DE122008000068I2 (de) 2011-06-16
FR08C0052I1 (enEXAMPLES) 2009-02-27
BRPI0015947A (pt) 2002-08-20
PL356097A1 (en) 2004-06-14
ES2237496T3 (es) 2005-08-01
ATE288450T1 (de) 2005-02-15
JP2006348301A (ja) 2006-12-28
CN1188428C (zh) 2005-02-09
KR20020063900A (ko) 2002-08-05
NO328790B1 (no) 2010-05-18
DK1259550T3 (da) 2005-04-25
FR08C0052I2 (fr) 2009-12-18
DE122008000068I1 (de) 2009-04-23
JP2003515623A (ja) 2003-05-07
TWI242015B (en) 2005-10-21
HUP0203755A2 (hu) 2003-04-28
CY2008018I1 (el) 2009-11-04
DE60017947D1 (de) 2005-03-10
RU2260013C2 (ru) 2005-09-10
EP1259550A1 (en) 2002-11-27
BRPI0015947B1 (pt) 2012-02-07
US6670340B1 (en) 2003-12-30
JP3880041B2 (ja) 2007-02-14
WO2001040316A1 (en) 2001-06-07
KR100716524B1 (ko) 2007-05-10
HUP0203755A3 (en) 2003-10-28
CN1402737A (zh) 2003-03-12
US6949527B2 (en) 2005-09-27
IL149423A0 (en) 2002-11-10
HU227451B1 (en) 2011-06-28
NO20022522D0 (no) 2002-05-28
NZ518752A (en) 2003-03-28
AU5438001A (en) 2001-06-12
NO2010019I1 (no) 2010-11-22
EP1259550B1 (en) 2005-02-02
PT1259550E (pt) 2005-05-31
CZ298206B6 (cs) 2007-07-18
AU776536B2 (en) 2004-09-16
CA2390463C (en) 2009-02-03
NL300356I2 (nl) 2009-04-01
PL203012B1 (pl) 2009-08-31
MXPA02004940A (es) 2003-05-23
ZA200203538B (en) 2003-08-04
LU91501I9 (enEXAMPLES) 2019-01-02
HK1049489A1 (en) 2003-05-16
NO20022522L (no) 2002-05-28
CO5251450A1 (es) 2003-02-28
US20040029833A1 (en) 2004-02-12
CY2008018I2 (el) 2009-11-04
BE2008C047I2 (enEXAMPLES) 2019-12-11
USRE44733E1 (en) 2014-01-28
SK286282B6 (sk) 2008-06-06
BRPI0015947B8 (pt) 2021-07-06
DE60017947T2 (de) 2005-06-23
CA2390463A1 (en) 2001-06-07
SK7262002A3 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
AR026605A1 (es) Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacos
LU91160I2 (fr) Ezetimible ou ses sels acceptés en combinaison avec Simvastatin (Inegy/Vytorin).
CY1105047T1 (el) Ενωσεις πυριδοπυριμιδινονης, η μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τις περιεχουν
EA200400432A1 (ru) Производные мочевины
FI915282A0 (fi) Mono-n-substituerade 1,4,7,10-tetra -azacyklododekanderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska aemnen.
AR048652A1 (es) 4-fenilamino-quinazolin-6-il-amidas
CY1109153T1 (el) Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης
ES2079534T3 (es) Derivados de polietilenglicol, sus peptidos modificados, metodos para producirlos y uso de los peptidos modificados.
EA200200938A1 (ru) Фармацевтические композиции, содержащие производные азетидина, новые производные азетидина и их получение
CY1106674T1 (el) Αζαδικυκλικοι ετεροκυκλοι σαν ρυθμιστες υποδοχεα κανναβινοειδους
CY1110694T1 (el) Μεθοδος παρασκευης παραγωγων της εχινοκανδινης
AR022423A1 (es) Compuestos derivados de acidos 2,3,4,5-tetrahidro-1h-[1,4]benzodiazepina-3-hidroxamicos, composicion farmaceutica que los comprenden, y el uso de losmismos para la manufactura de un medicamento
NO990583D0 (no) Cykliske eterforbindelser som natriumkanalmodulatorer
AR025103A1 (es) Quelantes quimicos para la reversion del bloqueo neuromuscular inducido por farmacos
DE69202286D1 (de) Verfahren zur Färbung keratinischer Fasern mit Isatin oder Isatinderivaten zusammen mit Aminopyrimidin oder Aminopyridin und Färbemittel.
AR030203A1 (es) Derivados de carbamato de 2-(s)-hidroximutilina, composiciones farmaceuticas que los comprenden, procedimiento para prepararlos y 2(s), 11-dihidroxi protegida-mutilina como compuesto intermediario
BR9708639A (pt) Composição estabilizadora
IT1317048B1 (it) Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie
BR9812892A (pt) 2 4-diamino-1,3,5-triazinas substituìdas e seu emprego como herbicidas
AR017851A1 (es) Composicion farmaceutica que comprende un eter carboxialquilico y una estatina, primera composicion farmaceutica para el uso con una segunda composicionfarmaceutica para lograr un efecto hipolipidemico y controlar el riesgo cardiaco adverso en un mamifero y conjunto para lograr dichos efectos terape
BR0308018A (pt) Composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo, pró-droga, método para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hirolisável in vivo, composição farmacêutica, e, processo para a preparação de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo
PT1197485E (pt) Derivados de ciclobuteno-diona e a sua utilizacao no tratamento da aterosclerose
DK1257552T3 (da) Xanthinderivater, mellemprodukter og anvendelse til behandling af osteoporose
BR9510429A (pt) Composto composição farmacêutica processo para produzir o composto e uso do composto
FI960487A0 (fi) Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia

Legal Events

Date Code Title Description
FG Grant, registration